# Swedish Drug-elution Trial in Peripheral Arterial Disease

Study · id `cardio:ct-nct02051088` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02051088](<https://clinicaltrials.gov/study/NCT02051088>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT02051088

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 3556 participants.

## Technical summary

Registry record NCT02051088. Randomized; single masking; primary purpose treatment. Start 2014-11 (actual); primary completion 2025-04-30 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 3556 participants (enrolled count; ClinicalTrials.gov record NCT02051088, source copy `cardio:ctgov-nct02051088-2025-08-03`, retrieved 2026-10-31)
- Started: 2014-11 (actual) (ClinicalTrials.gov record NCT02051088, source copy `cardio:ctgov-nct02051088-2025-08-03`, retrieved 2026-10-31)
- Primary completion: 2025-04-30 (actual) (ClinicalTrials.gov record NCT02051088, source copy `cardio:ctgov-nct02051088-2025-08-03`, retrieved 2026-10-31)
- Completion: 2026-12-31 (anticipated) (ClinicalTrials.gov record NCT02051088, source copy `cardio:ctgov-nct02051088-2025-08-03`, retrieved 2026-10-31)
- Countries: Sweden (ClinicalTrials.gov record NCT02051088, source copy `cardio:ctgov-nct02051088-2025-08-03`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "ACTIVE\_NOT\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02051088-2025-08-03`, retrieved 2026-10-31)

## The registry's words

- Brief title: Swedish Drug-elution Trial in Peripheral Arterial Disease
- Acronym: SWEDEPAD
- Condition: Peripheral Arterial Disease
- Condition: Critical Limb Ischemia
- Condition: Intermittent Claudication
- Intervention (Procedure): Revascularization with drug-eluting technology
- Intervention (Procedure): Revascularization without drug-eluting technology
- Intervention (Device): drug-coated balloons and/or drug-eluting stents
- Lead sponsor: Sahlgrenska University Hospital
- Lead sponsor class: OTHER
- Collaborator: The Swedish Research Council
- Collaborator class: OTHER\_GOV
- Collaborator: Swedish Heart Lung Foundation
- Collaborator class: OTHER
- Collaborator: Uppsala University
- Collaborator class: OTHER
- Collaborator: The Swedish National Registry for Vascular Surgery
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Peripheral artery disease (`cardio:peripheral-artery-disease`)
- Registry lists this organization as the lead sponsor: Sahlgrenska University Hospital (`cardio:org-sahlgrenska-university-hospital`)
- Registry lists this organization as a collaborator: The Swedish Research Council (`cardio:org-the-swedish-research-council`)
- Registry lists this organization as a collaborator: Swedish Heart Lung Foundation (`cardio:org-swedish-heart-lung-foundation`)
- Registry lists this organization as a collaborator: Uppsala University (`cardio:org-uppsala-university`)

## Provenance

Content hash: 027701b8bb06c8bd7ac90328e1a47508911ba30dc7e833a9e8576fdd4dc12a4d
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
